186 related articles for article (PubMed ID: 12812348)
21. Frequency and Clinical Significance of Localized Adverse Events following Mass Drug Administration for Lymphatic Filariasis in an Endemic Area in South India.
Kuttiatt VS; Somani RK; Swaminathan S; Krishnamoorthy K; Weil GJ; Purushothaman J
Am J Trop Med Hyg; 2020 Jan; 102(1):96-99. PubMed ID: 31769393
[TBL] [Abstract][Full Text] [Related]
22. Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study.
Dubray CL; Sircar AD; Beau de Rochars VM; Bogus J; Direny AN; Ernest JR; Fayette CR; Goss CW; Hast M; O'Brian K; Pavilus GE; Sabin DF; Wiegand RE; Weil GJ; Lemoine JF
PLoS Negl Trop Dis; 2020 Jun; 14(6):e0008298. PubMed ID: 32511226
[TBL] [Abstract][Full Text] [Related]
23. The pharmacokinetics, safety and tolerability of the co-administration of diethylcarbamazine and albendazole.
Shenoy RK; Suma TK; John A; Arun SR; Kumaraswami V; Fleckenstein LL; Na-Bangchang K
Ann Trop Med Parasitol; 2002 Sep; 96(6):603-14. PubMed ID: 12396323
[TBL] [Abstract][Full Text] [Related]
24. Country Reports on Practical Aspects of Conducting Large-Scale Community Studies of the Tolerability of Mass Drug Administration with Ivermectin/Diethylcarbamazine/Albendazole for Lymphatic Filariasis.
Jambulingam P; Subramanian S; Krishnamoorthy K; Supali T; Fischer P; Dubray C; Fayette C; Lemoine JF; Laman M; King C; Samuela J; Hardy M; Weil GJ
Am J Trop Med Hyg; 2022 May; 106(5_Suppl):18-25. PubMed ID: 35292582
[TBL] [Abstract][Full Text] [Related]
25. The development of albendazole for lymphatic filariasis.
Horton J
Ann Trop Med Parasitol; 2009 Oct; 103 Suppl 1():S33-40. PubMed ID: 19843396
[TBL] [Abstract][Full Text] [Related]
26. Treatment of the microfilaraemia of asymptomatic brugian filariasis with single doses of ivermectin, diethylcarbamazine or albendazole, in various combinations.
Shenoy RK; Dalia S; John A; Suma TK; Kumaraswami V
Ann Trop Med Parasitol; 1999 Sep; 93(6):643-51. PubMed ID: 10707109
[TBL] [Abstract][Full Text] [Related]
27. Economic performance and cost-effectiveness of using a DEC-salt social enterprise for eliminating the major neglected tropical disease, lymphatic filariasis.
Sharma S; Smith ME; Reimer J; O'Brien DB; Brissau JM; Donahue MC; Carter CE; Michael E
PLoS Negl Trop Dis; 2019 Jul; 13(7):e0007094. PubMed ID: 31260444
[TBL] [Abstract][Full Text] [Related]
28. Community-based study to assess the efficacy of DEC plus ALB against DEC alone on bancroftian filarial infection in endemic areas in Tamil Nadu, south India.
Rajendran R; Sunish IP; Mani TR; Munirathinam A; Arunachalam N; Satyanarayana K; Dash AP
Trop Med Int Health; 2006 Jun; 11(6):851-61. PubMed ID: 16772007
[TBL] [Abstract][Full Text] [Related]
29. Albendazole for lymphatic filariasis.
Addiss D; Critchley J; Ejere H; Garner P; Gelband H; Gamble C;
Cochrane Database Syst Rev; 2004; (1):CD003753. PubMed ID: 14974034
[TBL] [Abstract][Full Text] [Related]
30. Evidence for the use of albendazole for the elimination of lymphatic filariasis.
Sunish IP; Rajendran R; Mani TR; Dash AP; Tyagi BK
Lancet Infect Dis; 2006 Mar; 6(3):125-6. PubMed ID: 16500593
[No Abstract] [Full Text] [Related]
31. Albendazole for lymphatic filariasis.
Critchley J; Addiss D; Gamble C; Garner P; Gelband H; Ejere H;
Cochrane Database Syst Rev; 2005 Oct; (4):CD003753. PubMed ID: 16235339
[TBL] [Abstract][Full Text] [Related]
32. Adverse reactions following diethylcarbamazine (DEC) intake in 'endemic normals', microfilaraemics and elephantiasis patients.
Haarbrink M; Terhell AJ; Abadi GK; Mitsui Y; Yazdanbakhsh M
Trans R Soc Trop Med Hyg; 1999; 93(1):91-6. PubMed ID: 10492800
[TBL] [Abstract][Full Text] [Related]
33. Two-year follow-up of the microfilaraemia of asymptomatic brugian filariasis, after treatment with two, annual, single doses of ivermectin, diethylcarbamazine and albendazole, in various combinations.
Shenoy RK; John A; Babu BS; Suma TK; Kumaraswami V
Ann Trop Med Parasitol; 2000 Sep; 94(6):607-14. PubMed ID: 11064762
[TBL] [Abstract][Full Text] [Related]
34. Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature.
Budge PJ; Herbert C; Andersen BJ; Weil GJ
PLoS Negl Trop Dis; 2018 May; 12(5):e0006454. PubMed ID: 29768412
[TBL] [Abstract][Full Text] [Related]
35. Community empowerment in the control of lymphatic filariasis in Misima, Milne Bay Province using diethylcarbamazine in combination with albendazole.
Selve BP; Bwadua S; Misa M; James K; Usurup JP; Turner P; Melrose W; Yad W; Samuel R; Eddie C
P N G Med J; 2000; 43(3-4):183-7. PubMed ID: 11939299
[TBL] [Abstract][Full Text] [Related]
36. Community-wide reduction in prevalence and intensity of intestinal helminths as a collateral benefit of lymphatic filariasis elimination programs.
De Rochars MB; Direny AN; Roberts JM; Addiss DG; Radday J; Beach MJ; Streit TG; Dardith D; Lafontant JG; Lammie PJ
Am J Trop Med Hyg; 2004 Oct; 71(4):466-70. PubMed ID: 15516644
[TBL] [Abstract][Full Text] [Related]
37. Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti.
de Kraker ME; Stolk WA; van Oortmarssen GJ; Habbema JD
Trop Med Int Health; 2006 May; 11(5):718-28. PubMed ID: 16640625
[TBL] [Abstract][Full Text] [Related]
38. A multicenter, community-based, mixed methods assessment of the acceptability of a triple drug regimen for elimination of lymphatic filariasis.
Krentel A; Basker N; Beau de Rochars M; Bogus J; Dilliott D; Direny AN; Dubray C; Fischer PU; Ga AL; Goss CW; Hardy M; Howard C; Jambulingam P; King CL; Laman M; Lemoine JF; Mallya S; Robinson LJ; Samuela J; Schechtman KB; Steer AC; Supali T; Tavul L; Weil GJ
PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009002. PubMed ID: 33657090
[TBL] [Abstract][Full Text] [Related]
39. The influence of the mass administration of diethylcarbamazine, alone or with albendazole, on the prevalence of filarial antigenaemia.
Rajendran R; Sunish IP; Mani TR; Munirathinam A; Abdullah SM; Augustin DJ; Satyanarayana K
Ann Trop Med Parasitol; 2002 Sep; 96(6):595-602. PubMed ID: 12396322
[TBL] [Abstract][Full Text] [Related]
40. Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
Fischer PU; King CL; Jacobson JA; Weil GJ
PLoS Negl Trop Dis; 2017 Jan; 11(1):e0005163. PubMed ID: 28056015
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]